Colorectal Cancer Coalition

C3 Advocate Paulette Stallone Featured in New York Times

Today, the New York Times published a special profiling 522 cancer survivors in order to highlight some of the challenges they faced after completing treatment.  The interviews share insights about life after cancer from survivors across the country.  C3 Advocate Paulette Stallone is one of the survivors featured in the article.

Paulette was just 44 years old when she was diagnosed with rectal cancer.  After 14 months of treatment, this February, she got the good news that she is cancer free.  Like so many advocates, Paulette has turned her fight with cancer into a mission to help others.  In March, she organized the inaugural “Paulette Steps Toward Cancer Wellness” 5K run/1-mile walk to raise money for CentraState Hospital in New Jersey where she received her treatment.

Paulette had a very busy March.  Not only did she organize a run that attracted more than 350 participants and raised over $26,000 for CentraState Hospital, she also participated in C3′s Congressional Butt-In.  She recruited friends and colleagues from across New Jersey to participate in the Butt-In, and thanks to her efforts every member of the New Jersey Congressional Delegation received calls from constituents asking them to support the Colorectal Cancer Prevention, Early Detection, and Treatment Act (H.R. 1189).

Read more about Paulette’s story as well as interviews with other cancer survivors in the New York Times article.

This news article was originally posted on April 29th, 2010 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Catherine Knowles on April 29th, 2010
Tags: HR 1189

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Name Email (hidden) URL Comments (Basic HTML is allowed - a href, strong, em, blockquote)